We further showed that NeoAgs are major targets of T cells reactivated by ICT and that anti-CTLA-4 and anti-PD-1 ICT induces changes in both CD4 and CD8 T cells within the tumor microenvironment (TME)13,18–21, consistent with findings from others22,23. The gene discussed is PDCD1; the disease is neoplasm.